SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer concludes sale of PAPPL to PAHIL

10 Dec 2012 Evaluate

Pfizer has completed the sale of entire equity stake of its wholly owned subsidiary Pfizer Animal Pharma (PAPPL) to Pfizer Animal Health India (PAHIL), a 100% indirect subsidiary of Pfizer Inc., USA. The company has received the consideration amount of Rs 471.60 crore for the same from PAHIL.

Earlier, Pfizer had received board approval which was held on November 08, 2012 for sale of PAPPL to PAHIL for a consideration of Rs 471.60 crore.

Pfizer manufactures prescription drugs such as Viagra, Lyrica, Viagra, Dolonex Gel, Ponstan, Citralka Liquid, and many more. Its first production unit was set up at Darukhanna in Mumbai.

Pfizer Share Price

4811.05 61.45 (1.29%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×